2-Methylsulfinyl-4-methyl-6-[(3-hydroxyphenyl)methyl]-4H-thieno[3,2-b]pyrrole[3,2-d]pyridazinone

ID: ALA1082815

Cas Number: 1222535-34-3

PubChem CID: 44543627

Max Phase: Preclinical

Molecular Formula: C17H15N3O3S2

Molecular Weight: 373.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(O)c3)c(=O)c21

Standard InChI:  InChI=1S/C17H15N3O3S2/c1-19-13-7-14(25(2)23)24-16(13)12-8-18-20(17(22)15(12)19)9-10-4-3-5-11(21)6-10/h3-8,21H,9H2,1-2H3

Standard InChI Key:  PTQIMFRZBDFMMQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    9.3956   -5.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1068   -4.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8332   -5.2161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5402   -4.7887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5249   -3.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8026   -3.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0915   -3.9867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9605   -5.2721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6735   -4.8440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6538   -4.0127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9271   -3.6134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2347   -4.8713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2212   -4.0381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4507   -5.1393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9503   -4.4753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4274   -3.7938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9261   -3.1265    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.1388   -3.3987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1512   -4.2307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9755   -6.0992    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2056   -5.9301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4134   -2.9850    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.4121   -2.1579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6983   -3.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2656   -5.1891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
 12  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 13  1  0
 12 13  2  0
 13 16  1  0
 15 14  1  0
 14 12  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
  8 20  2  0
 14 21  1  0
  9  1  1  0
 18 22  1  0
 22 23  1  0
 22 24  1  0
  4 25  1  0
M  CHG  2  22   1  23  -1
M  END

Associated Targets(Human)

PKM Tchem Pyruvate kinase isozymes M1/M2 (14841 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PKLR Tclin Pyruvate kinase isozymes R/L (2627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PYK Pyruvate kinase (6726 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.46Molecular Weight (Monoisotopic): 373.0555AlogP: 2.44#Rotatable Bonds: 3
Polar Surface Area: 83.11Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.41CX Basic pKa: CX LogP: 1.66CX LogD: 1.66
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.56Np Likeness Score: -1.05

References

1. Jiang JK, Boxer MB, Vander Heiden MG, Shen M, Skoumbourdis AP, Southall N, Veith H, Leister W, Austin CP, Park HW, Inglese J, Cantley LC, Auld DS, Thomas CJ..  (2010)  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase.,  20  (11): [PMID:20451379] [10.1016/j.bmcl.2010.04.015]
2. PubChem BioAssay data set,